CRIM-negative infantile Pompe disease: Characterization of immune responses in patients treated with ERT monotherapy

PURPOSE: Enzyme replacement therapy (ERT) with recombinant human GAA (rhGAA) prolongs survival in infantile Pompe disease (IPD). However, the majority of cross reactive immunologic material (CRIM)-negative (CN) patients have immune responses with significant clinical decline despite continued ERT. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Berrier, Kathryn L., Kazi, Zoheb B., Prater, Sean N., Bali, Deeksha S., Goldstein, Jennifer, Stefanescu, Mihaela C., Rehder, Catherine W., Botha, Eleanor G., Ellaway, Carolyn, Bhattacharya, Kaustuv, Tylki-Szymanska, Anna, Karabul, Nesrin, Rosenburg, Amy S., Kishnani, Priya S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561024/
https://www.ncbi.nlm.nih.gov/pubmed/25741864
http://dx.doi.org/10.1038/gim.2015.6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561024/
https://www.ncbi.nlm.nih.gov/pubmed/25741864
http://dx.doi.org/10.1038/gim.2015.6

Ejemplares similares